These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10358444)

  • 21. [Pelvic exenteration in advanced and or recurrent rectal cancer].
    Koyama Y; Moriya Y; Hojo K
    Nihon Geka Gakkai Zasshi; 1987 Jan; 88(1):58-62. PubMed ID: 2434830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization of interventional radiology in the postoperative management of patients after surgery for locally advanced and recurrent rectal cancer.
    Llaguna OH; Calvo BF; Stitzenberg KB; Deal AM; Burke CT; Dixon RG; Stavas JM; Meyers MO
    Am Surg; 2011 Aug; 77(8):1086-90. PubMed ID: 21944529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer.
    Yamada K; Ishizawa T; Niwa K; Chuman Y; Akiba S; Aikou T
    Br J Surg; 2001 Jul; 88(7):988-93. PubMed ID: 11442533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pelvic exenteration for advanced primary rectal cancer in male patients.
    Verschueren RC; Mulder NH; Hooykaas JA; Szabo BG; Karrenbeld A
    Clin Oncol (R Coll Radiol); 1998; 10(5):318-21. PubMed ID: 9848333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical management of pelvic malignancy: role of extended abdominoperineal resection/exenteration/abdominal sacral resection.
    Wanebo HJ; Begossi G; Varker KA
    Surg Oncol Clin N Am; 2005 Apr; 14(2):197-224. PubMed ID: 15817235
    [No Abstract]   [Full Text] [Related]  

  • 26. Outcomes of total pelvic exenteration for colorectal cancer.
    Nishio M; Sakakura C; Nagata T; Miyashita A; Hamada T; Ikoma H; Kubota T; Nakanishi M; Kimura A; Ichikawa D; Kikuchi S; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Taniguchi H; Sonoyama T; Hagiwara A; Otsuji E
    Hepatogastroenterology; 2009; 56(96):1637-41. PubMed ID: 20214208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extended resection and pelvic exenteration in distal third rectal cancer.
    García-Granero E; Frasson M; Trallero M
    Cir Esp; 2014 Mar; 92 Suppl 1():40-7. PubMed ID: 24842690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical management of the locally advanced pelvic malignancy--the colorectal surgeon's view.
    Tjandra JJ
    Ann Acad Med Singap; 1995 Mar; 24(2):271-6. PubMed ID: 7544559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recent management of metastatic colorectal cancer].
    Kato T; Hirai T; Yasui K
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1865-72. PubMed ID: 9797809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical strategy for local recurrence after resection of rectal cancer.
    Fujii S; Shimada H; Yamagishi S; Ota M; Ichikawa Y; Kunisaki C; Ike H; Ohki S
    Hepatogastroenterology; 2009; 56(91-92):667-71. PubMed ID: 19621677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer.
    Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD
    Ann Surg; 2013 Dec; 258(6):1007-13. PubMed ID: 23364701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Posterior pelvic exenteration for primary rectal cancer.
    Bannura GC; Barrera AE; Cumsille MA; Contreras JP; Melo CL; Soto DC; Mansilla JE
    Colorectal Dis; 2006 May; 8(4):309-13. PubMed ID: 16630235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total pelvic exenteration as a therapeutic option in advanced malignant disease of the pelvis.
    Kraybill WG; Lopez MJ; Bricker EM
    Surg Gynecol Obstet; 1988 Mar; 166(3):259-63. PubMed ID: 3344455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results.
    Melton GB; Paty PB; Boland PJ; Healey JH; Savatta SG; Casas-Ganem JE; Guillem JG; Weiser MR; Cohen AM; Minsky BD; Wong WD; Temple LK
    Dis Colon Rectum; 2006 Aug; 49(8):1099-107. PubMed ID: 16779712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pelvic exenteration: a perspective from a regional cancer center in India.
    Pandey D; Zaidi S; Mahajan V; Kannan R
    Indian J Cancer; 2004; 41(3):109-14. PubMed ID: 15472408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Evolution of Pelvic Exenteration Practice at a Single Center: Lessons Learned from over 500 Cases.
    Koh CE; Solomon MJ; Brown KG; Austin K; Byrne CM; Lee P; Young JM
    Dis Colon Rectum; 2017 Jun; 60(6):627-635. PubMed ID: 28481857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of right- and left-sided colonic and rectal cancer following surgical resection.
    Suttie SA; Shaikh I; Mullen R; Amin AI; Daniel T; Yalamarthi S
    Colorectal Dis; 2011 Aug; 13(8):884-9. PubMed ID: 20594201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of epidermal growth factor receptor (EGFR) expression on loco-regional recurrence after preoperative radiotherapy in rectal cancer.
    Azria D; Bibeau F; Barbier N; Zouhair A; Lemanski C; Rouanet P; Ychou M; Senesse P; Ozsahin M; Pèlegrin A; Dubois JB; Thèzenas S
    BMC Cancer; 2005 Jun; 5():62. PubMed ID: 15967033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment strategy for locally recurrent rectal cancer.
    Moriya Y
    Jpn J Clin Oncol; 2006 Mar; 36(3):127-31. PubMed ID: 16598032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term surveillance of patients operated on for colorectal cancers].
    Mosnier H
    Ann Gastroenterol Hepatol (Paris); 1985 Dec; 21(6):351-3. PubMed ID: 4096495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.